Anthony Scott Praill serves as Executive at DelMar Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Anthony Scott Praill has executed 19 insider transactions totaling $19.5K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 1, 2022 involved receiving (via award) 240,087 shares valued at $0.
Anthony Scott Praill currently holds 277,273 shares of DelMar Pharmaceuticals, Inc. (DMPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Anthony Scott Praill has been a net buyer of DMPI stock. They have purchased $19.5K and sold $0 worth of shares.
Anthony Scott Praill's most recent insider trade was on Aug 1, 2022, when they sold 240,087 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $0.68 |
| Discretionary |
| Apr 29, 2021 | KTRA | $0 | Conversion | 938 | $N/A | Discretionary |
| Apr 29, 2021 | KTRA | $0 | Other | 8 | $N/A | Discretionary |
| Mar 31, 2021 | KTRA | $0 | Other | 22 | $N/A | Discretionary |
| Dec 31, 2020 | KTRA | $0 | Other | 22 | $N/A | Discretionary |
| Sep 30, 2020 | KTRA | $0 | Other | 22 | $N/A | Discretionary |
| Jun 30, 2020 | DMPI | $0 | Other | 22 | $N/A | Discretionary |
| Mar 31, 2020 | DMPI | $0 | Other | 22 | $N/A | Discretionary |
| Dec 31, 2019 | DMPI | $0 | Other | 22 | $N/A | Discretionary |
| Sep 30, 2019 | DMPI | $0 | Other | 22 | $N/A | Discretionary |
| Jun 28, 2019 | DMPI | $0 | Other | 22 | $N/A | Discretionary |
| Mar 29, 2019 | DMPI | $103 | Other | 211 | $0.49 | Discretionary |
| Dec 31, 2018 | DMPI | $72 | Other | 211 | $0.34 | Discretionary |
| Sep 28, 2018 | DMPI | $675 | Other | 211 | $3.20 | Discretionary |
| Jun 29, 2018 | DMPI | $675 | Other | 211 | $3.20 | Discretionary |
| Mar 30, 2018 | DMPI | $675 | Other | 211 | $3.20 | Discretionary |
| Dec 31, 2017 | DMPI | $675 | Other | 211 | $3.20 | Discretionary |
| Dec 31, 2017 | DMPI | $0 | Conversion | 25,000 | $N/A | Discretionary |